ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/01/25 | 3,360 | 3,360 | 3,245 | 3,320 | -55 | -1.6% | 94,100 |
| 2022/01/24 | 3,300 | 3,380 | 3,295 | 3,375 | +90 | +2.7% | 73,000 |
| 2022/01/21 | 3,315 | 3,330 | 3,255 | 3,285 | -10 | -0.3% | 99,100 |
| 2022/01/20 | 3,245 | 3,325 | 3,245 | 3,295 | +25 | +0.8% | 53,500 |
| 2022/01/19 | 3,345 | 3,375 | 3,255 | 3,270 | -80 | -2.4% | 101,200 |
| 2022/01/18 | 3,375 | 3,390 | 3,345 | 3,350 | -5 | -0.1% | 48,600 |
| 2022/01/17 | 3,320 | 3,385 | 3,320 | 3,355 | -10 | -0.3% | 39,400 |
| 2022/01/14 | 3,350 | 3,380 | 3,320 | 3,365 | -15 | -0.4% | 87,600 |
| 2022/01/13 | 3,420 | 3,425 | 3,380 | 3,380 | -40 | -1.2% | 36,600 |
| 2022/01/12 | 3,390 | 3,450 | 3,385 | 3,420 | +60 | +1.8% | 68,200 |
| 2022/01/11 | 3,325 | 3,370 | 3,305 | 3,360 | +65 | +2% | 76,800 |
| 2022/01/07 | 3,365 | 3,380 | 3,290 | 3,295 | -70 | -2.1% | 105,300 |
| 2022/01/06 | 3,375 | 3,410 | 3,365 | 3,365 | -50 | -1.5% | 57,000 |
| 2022/01/05 | 3,410 | 3,435 | 3,385 | 3,415 | +15 | +0.4% | 91,100 |
| 2022/01/04 | 3,295 | 3,415 | 3,295 | 3,400 | +125 | +3.8% | 167,600 |
| 2021/12/30 | 3,280 | 3,305 | 3,265 | 3,275 | -45 | -1.4% | 64,300 |
| 2021/12/29 | 3,320 | 3,360 | 3,305 | 3,320 | -5 | -0.2% | 58,200 |
| 2021/12/28 | 3,295 | 3,340 | 3,290 | 3,325 | +35 | +1.1% | 51,000 |
| 2021/12/27 | 3,320 | 3,320 | 3,280 | 3,290 | -35 | -1.1% | 50,600 |
| 2021/12/24 | 3,355 | 3,355 | 3,320 | 3,325 | -5 | -0.2% | 23,700 |
| 2021/12/23 | 3,355 | 3,355 | 3,315 | 3,330 | ±0 | ±0% | 32,700 |
| 2021/12/22 | 3,330 | 3,345 | 3,300 | 3,330 | +10 | +0.3% | 33,900 |
| 2021/12/21 | 3,330 | 3,335 | 3,290 | 3,320 | +60 | +1.8% | 63,700 |
| 2021/12/20 | 3,230 | 3,300 | 3,220 | 3,260 | -10 | -0.3% | 77,100 |
| 2021/12/17 | 3,350 | 3,350 | 3,230 | 3,270 | -105 | -3.1% | 304,600 |
| 2021/12/16 | 3,395 | 3,405 | 3,325 | 3,375 | +65 | +2% | 103,700 |
| 2021/12/15 | 3,315 | 3,370 | 3,300 | 3,310 | -10 | -0.3% | 58,300 |
| 2021/12/14 | 3,305 | 3,345 | 3,300 | 3,320 | +10 | +0.3% | 83,900 |
| 2021/12/13 | 3,345 | 3,355 | 3,290 | 3,310 | -30 | -0.9% | 91,200 |
| 2021/12/10 | 3,385 | 3,390 | 3,330 | 3,340 | -45 | -1.3% | 121,200 |
| 2021/12/09 | 3,390 | 3,410 | 3,365 | 3,385 | -5 | -0.1% | 71,200 |
| 2021/12/08 | 3,395 | 3,420 | 3,380 | 3,390 | +10 | +0.3% | 86,300 |
| 2021/12/07 | 3,275 | 3,395 | 3,270 | 3,380 | +110 | +3.4% | 113,000 |
| 2021/12/06 | 3,305 | 3,355 | 3,265 | 3,270 | -20 | -0.6% | 76,200 |
| 2021/12/03 | 3,185 | 3,295 | 3,155 | 3,290 | +85 | +2.7% | 100,800 |
| 2021/12/02 | 3,205 | 3,245 | 3,200 | 3,205 | -40 | -1.2% | 139,400 |
| 2021/12/01 | 3,235 | 3,280 | 3,220 | 3,245 | +10 | +0.3% | 131,400 |
| 2021/11/30 | 3,305 | 3,350 | 3,235 | 3,235 | -70 | -2.1% | 256,200 |
| 2021/11/29 | 3,365 | 3,365 | 3,295 | 3,305 | -90 | -2.7% | 112,500 |
| 2021/11/26 | 3,485 | 3,485 | 3,380 | 3,395 | -110 | -3.1% | 81,100 |
| 2021/11/25 | 3,530 | 3,545 | 3,500 | 3,505 | -10 | -0.3% | 58,600 |
| 2021/11/24 | 3,510 | 3,560 | 3,495 | 3,515 | -15 | -0.4% | 90,700 |
| 2021/11/22 | 3,505 | 3,545 | 3,495 | 3,530 | +25 | +0.7% | 95,700 |
| 2021/11/19 | 3,545 | 3,545 | 3,485 | 3,505 | -45 | -1.3% | 108,200 |
| 2021/11/18 | 3,585 | 3,605 | 3,530 | 3,550 | -75 | -2.1% | 146,200 |
| 2021/11/17 | 3,635 | 3,670 | 3,615 | 3,625 | -20 | -0.5% | 164,800 |
| 2021/11/16 | 3,690 | 3,700 | 3,645 | 3,645 | -50 | -1.4% | 58,300 |
| 2021/11/15 | 3,685 | 3,715 | 3,670 | 3,695 | +50 | +1.4% | 85,100 |
| 2021/11/12 | 3,575 | 3,660 | 3,575 | 3,645 | +55 | +1.5% | 92,400 |
| 2021/11/11 | 3,595 | 3,635 | 3,575 | 3,590 | +15 | +0.4% | 99,400 |
801～
850
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
